Skip to main content
. 2019 Mar 12;8(5):2535–2544. doi: 10.1002/cam4.2060

Table 1.

Characteristics of the whole cohort and by report of severe fatigue at 2 years after diagnosis

Characteristics Whole cohort N (%) No severe fatigue N (%) Severe fatigue N *(%) Adjusted OR, (95%CI)
Overall 1984 (100) 962 (48.5) 1022 (51.5)
PA before Dx
Active 1740 (87.7) 849 (48.8) 891 (51.2) 1
Inactive 231 (11.6) 102 (44.2) 129 (55.8) 0.92 (0.66‐1.27)
Missing 13 (0.7) 11 (84.6) 2 (15.4)
Change in PA since Dx
Increased/maintained PA 911 (45.9) 557 (61.1) 354 (38.9) 1
Decreased PA/remained inactive 1058 (53.3) 393 (37.2) 665 (62.9) 2.32 (1.85‐2.90)*
Missing 15 (0.8) 12 (80.0) 3 (20.0)
Tumor site
Breast 1213 (61.1) 452 (37.3) 761 (62.7) 1
Prostate 426 (21.5) 312 (73.2) 114 (26.8) 0.997 (0.51‐1.95)
Colorectal 345 (17.4) 198 (57.4) 147 (42.6) 1.17 (0.73‐1.87)
Gender
Female 1374 (69.3) 531 (38.7) 843 (61.4) 1
Male 610 (30.8) 431 (70.7) 179 (29.3) 0.63 (0.38‐1.04)
Age at diagnosis
Median (IQR) 52 (45‐65) 60 (48‐68) 49 (44‐60) 0.97 (0.95‐0.98)*
Marital status
In couple 16 01 (80.7) 783 (48.9) 818 (51.1) 1
Not in a couple 365 (18.4) 165 (45.2) 200 (54.8) 0.93 (0.70‐1.23)
Missing 18 (0.9) 14 (77.8) 4 (22.2)
Education
High school diploma or higher 1390 (70.1) 653 (47.0) 737 (53.0) 1
Less than high school 588 (29.6) 306 (52.0) 282 (48.0) 1.07 (0.82‐1.38)
  6 (0.3) 3 (50.0) 3 (50.0)
Employment
Employed/formation 887 (44.7) 369 (41.6) 518 (58.4) 1
Unemployed 298 (15.0) 90 (30.2) 208 (69.8) 1.01 (0.72‐1.40)
Retired/unable to work 790 (39.8) 494 (62.5) 296 (37.5) 0.95 (0.64‐1.41)
  9 (0.45) 9 (100.0) 0 (0)
Comorbidities
No 1059 (53.4) 559 (52.8) 500 (47.2) 1
Yes 925 (46.6) 403 (43.6) 522 (56.4) 1.68 (1.34‐2.11)*
Pain in the last 15 days before survey
Never 603 (30.4) 459 (76.1) 144 (23.9) 1
Sometimes 644 (32.5) 326 (50.6) 318 (49.4) 2.14 (1.63‐2.80)*
Often 341 (17.2) 91 (26.7) 250 (73.3) 5.37 (3.85‐7.51)*
Very often 255 (12.9) 58 (22.8) 197 (77.3) 6.30 (4.30‐9.21)*
Constantly 139 (7.0) 27 (19.4) 112 (80.6) 7.39 (4.47‐12.2)*
Missing 2 (0.1) 1 (50.0) 1 (50.0)
BMI before Dx
Underweight (<18.5) 43 (2.2) 13 (30.2) 30 (69.8) 1.42 (0.67‐3.01)
Normal (18.5‐24.9) 1056 (53.2) 473 (44.8) 583 (55.2) 1
Overweight (25.0‐29.9) 630 (31.8) 359 (57.0) 271 (43.0) 0.80 (0.62‐1.04)
Obese≥30.0) 243 (12.3) 115 (47.3) 128 (52.7) 0.90 (0.64‐1.28)
Missing 12 (0.6) 2 (16.7) 10 (83.3)
BMI variation since Dx
>‐10% and <+10% 1652 (83.3) 868 (52.5) 784 (47.5) 1
≤‐10.0% 78 (3.9) 23 (29.5) 55 (70.5) 2.01 (1.14‐3.55)**
≥+10.0% 238 (12.0) 68 (28.6) 170 (71.4) 1.22 (0.86‐1.73)
Missing 16 (0.8) 3 (18.8) 13 (81.3)
Alcohol consumption
<4/week 1559 (78.6) 699 (44.8) 860 (55.2) 1
≥4/week 419 (21.1) 257 (61.3) 162 (38.7) 0.99 (0.75‐1.33)
Missing 6 (0.3) 6 (100.0) 0 (0)
Smoking
No 1623 (81.8) 814 (50.2) 809 (49.9) 1
Yes 356 (17.9) 143 (40.2) 213 (59.8) 0.997 (0.75‐1.33)
Missing 5 (0.3) 5 (100) 0 (0)
Surgery
No 169 (8.5) 109 (64.5) 60 (35.5) 1
Yes 1814 (91.4) 852 (47.0) 962 (53.0) 0.63 (0.40‐1.002)
Missing 1 (0.1) 1 (100) 0 (0)
Chemotherapy
No 1084 (54.6) 628 (57.9) 456 (42.1) 1
Yes 900 (45.4) 334 (37.1) 566 (62.9) 1.22 (0.95‐1.56)
Radiation therapy
No 708 (35.7) 455 (64.3) 253 (35.7) 1
Yes 1273 (64.2) 506 (39.8) 767 (60.3) 1.38 (1.02‐1.88)***
Missing 3 (0.2) 1 (33.3) 2 (66.7)  
Endocrine therapy
No 1060 (53.4) 607 (57.3) 453 (42.7) 1
Yes 921 (46.4) 353 (38.3) 568 (61.7) 1.13 (0.87‐1.48)
Missing 3 (0.2) 2 (66.7) 1 (33.3)

PA: physical activity; Dx: diagnosis

*P < 0.001; ** P = 0.016; *** P = 0.036